Copyright
©The Author(s) 2022.
World J Hepatol. Dec 27, 2022; 14(12): 1985-1996
Published online Dec 27, 2022. doi: 10.4254/wjh.v14.i12.1985
Published online Dec 27, 2022. doi: 10.4254/wjh.v14.i12.1985
Figure 1 Combination therapy for hepatocellular carcinoma.
Top: Conventional treatment may lead to tumour recurrence due to cancer stem cell reactivation. Bottom: Combination therapy leads to increased efficacy of tumour eradication. Adapted from Dzobo et al[8]. HCC: Hepatocellular carcinoma; CSC: Cancer stem cell.
Figure 2 Liver cancer stem cells markers and their potential related functional pathways in hepatocellular carcinoma.
HCC: Hepatocellular carcinoma; LCSCs: Liver cancer stem cells.
- Citation: Li L, Xun C, Yu CH. Role of microRNA-regulated cancer stem cells in recurrent hepatocellular carcinoma. World J Hepatol 2022; 14(12): 1985-1996
- URL: https://www.wjgnet.com/1948-5182/full/v14/i12/1985.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i12.1985